Eric W. Roberts
Known title: Chief Business OfficerCIK: 0001576244
Eric W. Roberts's purchase track record
How the stock did after each of Eric W. Roberts's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
15
of 18 since May 16, 2023
Stock higher 6 months later
47%
3 months: 73%
Median 6-month return
-4.4%
3 months: +29.3%
Beat the S&P 500
47%
median -14.6% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/18/2025 | CALC | $8K | +52.6% | -77.0% | -0.4% |
| 9/9/2025 | CALC | $32K | +29.3% | -81.2% | +4.1% |
| 8/28/2025 | CALC | $29K | +56.4% | -79.8% | +6.3% |
| 8/15/2025 | CALC | $33K | +3.1% | -77.5% | +6.0% |
| 7/18/2025 | CALC | $16K | +6.6% | +70.4% | +10.2% |
| 7/9/2025 | CALC | $24K | +97.9% | +259.0% | +10.5% |
| 6/26/2025 | CALC | $6K | +110.5% | +335.7% | +12.8% |
| 6/5/2025 | CALC | $27K | +88.7% | +172.0% | +15.4% |
| 11/1/2024 | CALC | $200K | -27.1% | -50.1% | -0.7% |
| 8/21/2024 | CALC | $38K | -11.5% | -38.0% | +9.3% |
| 6/27/2024 | CALC | $16K | +43.5% | -4.4% | +10.1% |
| 4/1/2024 | CALC | $16K | +8.1% | +12.7% | +9.9% |
| 11/3/2023 | CALC | $74K | +95.8% | +101.4% | +17.6% |
| 8/21/2023 | CALC | $10K | -1.8% | +37.0% | +13.1% |
| 6/20/2023 | CALC | $17K | -35.3% | -34.4% | +8.6% |
| 6/7/2023 | CALC | $10K | pending | pending | — |
| 5/30/2023 | CALC | $41K | pending | pending | — |
| 5/16/2023 | CALC | $47K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CALC | ▲ Buy | Grant | 186,729 | $150K | 6/25/2026 | View on chart |
| CALC | ▲ Buy | Open Market | 2,500 | $8K | 9/18/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 3,400 | $9K | 9/15/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 5,000 | $16K | 9/12/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 2,343 | $7K | 9/9/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 800 | $2K | 8/29/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 9,200 | $26K | 8/28/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 3,508 | $10K | 8/21/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 2,000 | $5K | 8/20/2025 | View on chart |
| CALC | ▲ Buy | Option Exercise | 15,000 | $23K | 8/20/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 1,000 | $3K | 8/19/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 5,076 | $15K | 8/15/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 1,500 | $6K | 7/22/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 1,500 | $5K | 7/21/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 2,000 | $6K | 7/18/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 6,500 | $16K | 7/14/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 5,000 | $8K | 7/9/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 4,500 | $6K | 6/26/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 5,000 | $9K | 6/11/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 5,000 | $9K | 6/6/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 5,100 | $9K | 6/5/2025 | View on chart |
| CALC | ▲ Buy | Open Market | 53,333 | $200K | 11/1/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 2,000 | $7K | 8/23/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 3,000 | $11K | 8/23/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 5,000 | $20K | 8/21/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 5,000 | $16K | 6/27/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 3,254 | $13K | 4/2/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 746 | $3K | 4/1/2024 | View on chart |
| CALC | ▲ Buy | Grant | 91,086 | $389K | 2/5/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 2,400 | $7K | 11/6/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 3,700 | $10K | 11/3/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 11,249 | $32K | 11/3/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 3,200 | $9K | 11/3/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 5,860 | $16K | 11/3/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 736 | $2K | 8/25/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 714 | $2K | 8/22/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 1,750 | $6K | 8/21/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 200 | $706 | 6/26/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 1,200 | $4K | 6/26/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 500 | $2K | 6/23/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 2,000 | $8K | 6/21/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 500 | $2K | 6/20/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 485 | $3K | 6/8/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 1,500 | $8K | 6/7/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 3,200 | $16K | 6/6/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 1,687 | $8K | 6/2/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 2,000 | $9K | 6/1/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 2,000 | $8K | 5/30/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 2,000 | $7K | 5/23/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 6,000 | $18K | 5/22/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 3,000 | $8K | 5/17/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 3,500 | $9K | 5/16/2023 | View on chart |
| CALC | ▲ Buy | Open Market | 1,800 | $5K | 5/16/2023 | View on chart |
| CALC | ▲ Buy | Grant | 356,989 | — | 3/20/2023 | View on chart |
| CALC | ▲ Buy | Grant | 66,228 | — | 3/20/2023 | View on chart |
| CALC | ▲ Buy | Grant | 316,109 | — | 3/20/2023 | View on chart |
| CALC | ▲ Buy | Grant | 10,661 | — | 3/20/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
CALC files prospectus supplement for $25M ATM offering
CalciMedica has filed a prospectus supplement to conduct an at‑the‑market offering of up to $25 million of common stock. The filing indicates the company is seeking additional capital through a public offering. The stock currently trades near its $0.59 support level, and the neutral RSI suggests no strong momentum at present. The raise could provide funding for operations but may also dilute existing shareholders.
CALC files prospectus supplement for $25M ATM offering. CalciMedica has filed a prospectus supplement to conduct an at‑the‑market offering of up to $25 million of common stock. The filing indicates the company is seeking additional capital through a public offering. The stock currently trades near its $0.59 support level, and the neutral RSI suggests no strong momentum at present. The raise could provide funding for operations but may also dilute existing shareholders.